NCT04830813 2024-12-09
Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer
Chipscreen Biosciences, Ltd.
Phase 3 Completed
Clinical Trials
4 trialsNCT05271292 2024-07-16
SCLC
Chipscreen Biosciences, Ltd.
Phase 1/2 Recruiting
NCT05371899 2024-07-15
Mass Balance Study of [14C]Chiauranib
Chipscreen Biosciences, Ltd.
Phase NA Completed
NCT03216343 2023-08-30
Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer
Chipscreen Biosciences, Ltd.
Phase 1 Completed